Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Helicon Building Portfolio of Products for China

publication date: Dec 10, 2007

Helicon Group Limited is an Australian company that seeks to partner with small to medium sized Western biopharmas and medical device companies to promote and sell products in China that meet currently unfilled needs in that market. The company made its IPO last year. As part of its services, Helicon will manage regulatory approvals in China, then organize distribution and use its sales and marketing team to promote the products. Today, the company announced an agreement with Jewim Pharmaceticals to distribute drugs to oncology departments in hospitals. More details...

Stock Symbol: (ASX: HCG)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital